A nationwide evaluation of off-label drug utilization in Turkey

Ozdamar E. N., AKICI A., Alkan A., Bayar B., Gursoz H.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.4, pp.1229-1238, 2017 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.3906/sag-1609-129
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1229-1238
  • Keywords: Off-label drug use, systemic lupus erythematosus, mycophenolate, rituximab, SYSTEMIC-LUPUS-ERYTHEMATOSUS, MULTIPLE-SCLEROSIS, PULMONARY-HYPERTENSION, HOSPITALIZED CHILDREN, MEDICINE USE, RITUXIMAB, EFFICACY, PRESCRIPTIONS, EPIDEMIOLOGY, ONCOLOGY
  • Marmara University Affiliated: Yes

Abstract

Background/aim: Off-label drug use (OLDU) is under the control of the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate demographic and medical features of patients with OLDU applications in Turkey.